Search Results

ImmunoPrecise Antibodies and ChemPartner Biologics Announce PolyTope ® TATX-03 Antibody Cocktail Manufacturing Collaboration.

Shanghai ChemPartner announced today the appointment of Cheng-Chi Chao, Ph.D. as Vice President and Head of Immunotherapy and Inflammation.

Shanghai ChemPartner announced the additional investments the company is making into its biologics business unit to further its capabilities and capacity in biologics discovery through development and manufacturing.

Shanghai ChemPartner announced today the appointment of Steven Yu , Ph.D. as Vice President of Regulated Bioanalysis at the company headquarters in Shanghai, China . Dr. Yu has more than 15 years of experience in drug development and extensive expertise in assay development and validation, biomarker development, immunogenicity

Shanghai ChemPartner announced the opening of a new, state-of-the-art, 24,000 m2 laboratory facility in the Zhangjiang Hi-Tech Park in Shanghai, China.

Shanghai ChemPartner announced the appointment of Jie Jack Li, Ph.D. as a Vice President of Discovery Chemistry at the Company headquarters in Shanghai, China.

Shanghai ChemPartner announced they have entered into a non-exclusive agreement with the Mount Sinai Health System to assist in a trial production run of a component of the Mount Sinai COVID-19 serological assay that recently received Emergency Use Authorization from the U.S. Food and Drug Administration for use in Mount Sinai’s lab during the COVID-19 emergency declaration.

Shanghai ChemPartner a leading global Contract Research Organization (CRO), along with Berkeley Lights, Inc. (BLI), the leader in digital cell biology, announced today they have taken the next important step in their collaboration.

Shanghai ChemPartner today announced the appointment of Teddy Yang, Ph.D. as the Vice President and Head of Biologics Discovery at the company headquarters in Shanghai, China.

Shanghai ChemPartner, a leading life science organization providing high-quality and cost-effective drug discovery and development services, announced the closure of the merger deal with Quantum Hi-Tech China Biological.